LIXTE BIOTECHNOLOGY HOLDINGS
LIXTNASDAQUS Equity
$7.21▼ $0.43 (−6.00%)
Live1h—
24h▼ 6.0%
7d▼ 0.2%
14d▼ 0.2%
30d▼ 0.2%
1y▲ 50.2%
🏦Market Cap
$585.57B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
67
Fair
Earnings
Q2 · 2026Reported 2026-05-14Earnings Per Share
Actual
-0.18
Expected
—
—
—
YoY +37.90%
Revenue
Actual
—
Expected
—
—
—
Consensus estimates
Recent quarters
Q2 2026
-0.18
—
Q1 2026
-0.33
—
Q4 2025
-0.33
—
Q3 2025
-0.29
—